Alx Oncology Holdings Inc (ALXO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8301 -0.0013 (-0.16%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8701 +0.0400 (+4.82%) 17:58 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 4,796 | 2,067 | 0 | 0 |
| Cost of Goods | 4,360 | 1,880 | N/A | N/A |
| Gross Profit | 436 | 187 | N/A | N/A |
| Operating Expenses | 19,979 | 14,751 | 0 | 0 |
| Operating Income | -19,183 | -13,684 | N/A | N/A |
| Interest Expense | 21 | 0 | 0 | 0 |
| Other Income | -5 | -2 | 0 | 0 |
| Pre-tax Income | -19,209 | -13,686 | 0 | 0 |
| Income Tax | 34 | 45 | N/A | N/A |
| Net Income Continuous | -19,243 | -13,731 | N/A | N/A |
| Net Income | $-19,243 | $-13,731 | $N/A | $N/A |
| EPS Basic Total Ops | -7.56 | -6.33 | N/A | N/A |
| EPS Basic Continuous Ops | -6.26 | -4.99 | N/A | N/A |
| EPS Diluted Total Ops | -7.56 | -6.33 | N/A | N/A |
| EPS Diluted Continuous Ops | -6.26 | -4.99 | N/A | N/A |
| EBITDA(a) | $-18,743 | $-13,253 | $N/A | $N/A |